NEW YORK (GenomeWeb News) – Everist Genomics today announced a joint venture with Manipal Group to establish a business presence in India.

The joint venture will market Everist's diagnostic, prognostic, and therapeutic solutions through Manipal's healthcare network in India, which includes 15 hospitals, nine primary care clinics, and 55 community health centers. Additionally, the deal leverages Manipal's background in medical products, commercially viable infrastructure, and capabilities in the region, Everist said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A company hopes to capture the genetic diversity in India to power tailored therapeutics, BBC News reports.

Researchers tie variants in seven genes to insomnia risk, Live Science reports.

The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.

In PLOS this week: locus near OAS1 linked to Sjogren's syndrome, rotavirus reassortment events uncovered by sequencing, and more.